Azelnidipine and amlodipine anti-coronary atherosclerotic trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in junten medical university (ALPS-J).
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2015
At a glance
- Drugs Azelnidipine (Primary) ; Amlodipine
- Indications Atherosclerosis; Hypertension; Ischaemic heart disorders
- Focus Pharmacodynamics
- Acronyms ALPS-J
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.